Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritisANNALS OF THE RHEUMATIC DISEASESIF20.62017-01-01232OAAI
A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trialANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-0164PREAI
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)ANNALS OF THE RHEUMATIC DISEASESIF20.62014-01-01137PREAI
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trialsANNALS OF THE RHEUMATIC DISEASESIF20.62011-03-0191PREAI
Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation levelANNALS OF THE RHEUMATIC DISEASESIF20.62010-02-0184OAAI
Mutation of a Phosphorylatable Residue in Put3p Affects the Magnitude of Rapamycin-induced PUT1 Activation in a Gat1p-dependent MannerJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92009-09-018OAAI
The Effect of Ligand Binding on the Galactokinase Activity of Yeast Gal1p and Its Ability to Activate TranscriptionJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92009-01-0110OAAI
The Interaction between an Acidic Transcriptional Activator and Its Inhibitor THE MOLECULAR BASIS OF Gal4p RECOGNITION BY Gal80pJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92008-10-0136OAAI
Metabolic control of transcription:: paradigms and lessons from Saccharomyces cerevisiaeBIOCHEMICAL JOURNALIF4.32008-08-1245PREAI
Evaluation of predicted network modules in yeast metabolism using NMR-based metabolite profilingGENOME RESEARCHIF5.52007-03-0574OAAI
Understanding a transcriptional paradigm at the molecular level - The structure of yeast Gal80pJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92007-01-0131OAAI
RETRACTED: Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid - Role of NAD(P)H oxidase-derived superoxide and peroxynitrite (Retracted article. See vol. 42, 2022)ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42006-12-01145OAAI
Phosphorylation of Zn(II)2Cys6 proteins:: a cause or effect of transcriptional activation?BIOCHEMICAL SOCIETY TRANSACTIONSIF4.32006-10-2512PREAI
Contribution of amino acid side chains to sugar binding specificity in a galactokinase, Gal1p, and a transcriptional inducer, Gal3pJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92006-06-0114PREAI
Synovial cytokine and growth factor regulation of MMPs/TIMPs: Implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patientsINHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONSIF02006-02-0654PREAI
Molecular structure of Saccharomyces cerevisiae Gal1p, a bifunctional galactokinase and transcriptional inducerJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92005-11-0161PREAI
Eukaryotic transcription factors as direct nutrient sensorsTRENDS IN BIOCHEMICAL SCIENCESIF112005-07-0180PREAI
Molecular structure of human galactokinase - Implications for type II galactosemiaJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92005-03-01104OAAI
Signaling activation and repression of RNA polymerase II transcription in yeastBIOESSAYSIF2.72005-02-0529PREAI
Galactokinase: structure, function and role in type II galactosemiaCELLULAR AND MOLECULAR LIFE SCIENCESIF6.22004-10-0197PREAI